Company intelligence / Profile preview
Unique Biotech
- Ownership
- Private
- Development stage
- Commercial
Overview
Unique Biotech has over two decades of experience in developing and manufacturing clinically proven probiotics. Their products are supported by preclinical and clinical studies, with several proprietary strains having US FDA GRAS status. They supply globally to food, supplement, pharmaceutical, animal healthcare industries; their probiotics are documented for safety and efficacy[1][2][4].
- Therapeutic areas
- GastroenterologyImmunology
- Modalities
- Live biotherapeutic product therapyEnzyme replacement therapyNutraceuticals
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Unique Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Unique Biotech.